Cargando…
Mitochondrial dysfunction associated with TANGO2 deficiency
Transport and Golgi Organization protein 2 Homolog (TANGO2)-related disease is an autosomal recessive disorder caused by mutations in the TANGO2 gene. Symptoms typically manifest in early childhood and include developmental delay, stress-induced episodic rhabdomyolysis, and cardiac arrhythmias, alon...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866466/ https://www.ncbi.nlm.nih.gov/pubmed/35197517 http://dx.doi.org/10.1038/s41598-022-07076-9 |
_version_ | 1784655844834541568 |
---|---|
author | Heiman, Paige Mohsen, Al-Walid Karunanidhi, Anuradha St Croix, Claudette Watkins, Simon Koppes, Erik Haas, Richard Vockley, Jerry Ghaloul-Gonzalez, Lina |
author_facet | Heiman, Paige Mohsen, Al-Walid Karunanidhi, Anuradha St Croix, Claudette Watkins, Simon Koppes, Erik Haas, Richard Vockley, Jerry Ghaloul-Gonzalez, Lina |
author_sort | Heiman, Paige |
collection | PubMed |
description | Transport and Golgi Organization protein 2 Homolog (TANGO2)-related disease is an autosomal recessive disorder caused by mutations in the TANGO2 gene. Symptoms typically manifest in early childhood and include developmental delay, stress-induced episodic rhabdomyolysis, and cardiac arrhythmias, along with severe metabolic crises including hypoglycemia, lactic acidosis, and hyperammonemia. Severity varies among and within families. Previous studies have reported contradictory evidence of mitochondrial dysfunction. Since the clinical symptoms and metabolic abnormalities are suggestive of a broad dysfunction of mitochondrial energy metabolism, we undertook a broad examination of mitochondrial bioenergetics in TANGO2 deficient patients utilizing skin fibroblasts derived from three patients exhibiting TANGO2-related disease. Functional studies revealed that TANGO2 protein was present in mitochondrial extracts of control cells but not patient cells. Superoxide production was increased in patient cells, while oxygen consumption rate, particularly under stress, along with relative ATP levels and β-oxidation of oleate were reduced. Our findings suggest that mitochondrial function should be assessed and monitored in all patients with TANGO2 mutation as targeted treatment of the energy dysfunction could improve outcome in this condition. |
format | Online Article Text |
id | pubmed-8866466 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-88664662022-02-25 Mitochondrial dysfunction associated with TANGO2 deficiency Heiman, Paige Mohsen, Al-Walid Karunanidhi, Anuradha St Croix, Claudette Watkins, Simon Koppes, Erik Haas, Richard Vockley, Jerry Ghaloul-Gonzalez, Lina Sci Rep Article Transport and Golgi Organization protein 2 Homolog (TANGO2)-related disease is an autosomal recessive disorder caused by mutations in the TANGO2 gene. Symptoms typically manifest in early childhood and include developmental delay, stress-induced episodic rhabdomyolysis, and cardiac arrhythmias, along with severe metabolic crises including hypoglycemia, lactic acidosis, and hyperammonemia. Severity varies among and within families. Previous studies have reported contradictory evidence of mitochondrial dysfunction. Since the clinical symptoms and metabolic abnormalities are suggestive of a broad dysfunction of mitochondrial energy metabolism, we undertook a broad examination of mitochondrial bioenergetics in TANGO2 deficient patients utilizing skin fibroblasts derived from three patients exhibiting TANGO2-related disease. Functional studies revealed that TANGO2 protein was present in mitochondrial extracts of control cells but not patient cells. Superoxide production was increased in patient cells, while oxygen consumption rate, particularly under stress, along with relative ATP levels and β-oxidation of oleate were reduced. Our findings suggest that mitochondrial function should be assessed and monitored in all patients with TANGO2 mutation as targeted treatment of the energy dysfunction could improve outcome in this condition. Nature Publishing Group UK 2022-02-23 /pmc/articles/PMC8866466/ /pubmed/35197517 http://dx.doi.org/10.1038/s41598-022-07076-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Heiman, Paige Mohsen, Al-Walid Karunanidhi, Anuradha St Croix, Claudette Watkins, Simon Koppes, Erik Haas, Richard Vockley, Jerry Ghaloul-Gonzalez, Lina Mitochondrial dysfunction associated with TANGO2 deficiency |
title | Mitochondrial dysfunction associated with TANGO2 deficiency |
title_full | Mitochondrial dysfunction associated with TANGO2 deficiency |
title_fullStr | Mitochondrial dysfunction associated with TANGO2 deficiency |
title_full_unstemmed | Mitochondrial dysfunction associated with TANGO2 deficiency |
title_short | Mitochondrial dysfunction associated with TANGO2 deficiency |
title_sort | mitochondrial dysfunction associated with tango2 deficiency |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866466/ https://www.ncbi.nlm.nih.gov/pubmed/35197517 http://dx.doi.org/10.1038/s41598-022-07076-9 |
work_keys_str_mv | AT heimanpaige mitochondrialdysfunctionassociatedwithtango2deficiency AT mohsenalwalid mitochondrialdysfunctionassociatedwithtango2deficiency AT karunanidhianuradha mitochondrialdysfunctionassociatedwithtango2deficiency AT stcroixclaudette mitochondrialdysfunctionassociatedwithtango2deficiency AT watkinssimon mitochondrialdysfunctionassociatedwithtango2deficiency AT koppeserik mitochondrialdysfunctionassociatedwithtango2deficiency AT haasrichard mitochondrialdysfunctionassociatedwithtango2deficiency AT vockleyjerry mitochondrialdysfunctionassociatedwithtango2deficiency AT ghaloulgonzalezlina mitochondrialdysfunctionassociatedwithtango2deficiency |